An additional analysis by HR status showed that HER2-low breast cancer occurred more frequently in younger and pre-menopausal patients among HR-positive cases; and was associated with worse histological grade among HR-negative cases (Supplementary Tables S1,S2). This evidence concerns the gene ERBB2 and breast carcinoma.